Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/01/2026 ,inter alia, to consider and approve to consider and approve ....
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has informed BSE that a meeting of its Securities Transfer and Stakeholders Relationship Committee is scheduled for January 5, 2026. The committee will consider and approve a proposal to issue secured Non-Convertible Debentures (NCDs) on a private placement basis. The issuance will be within the borrowing limits already approved by the Board of Directors at its meeting held on July 28, 2025. The intimation has been made under SEBI LODR Regulations 29 and 50.
This is an execution step on a debt-raising plan already approved by the Board earlier, not a new borrowing decision. For equity shareholders, the move signals the company is tapping the debt market, but since it falls within pre-approved limits, it is unlikely to be a surprise. The actual size and pricing of the NCD issue on January 5 will determine any material impact on the stock.